Kyle Jenne has rejoined Ionis Pharmaceuticals Inc. as executive vice president, chief global product strategy officer, to lead all aspects of commercialization at the Company.   Onaiza Cadoret-Manier, chief global product strategy and operations officer, is leaving the company to pursue another opportunity. To support the transition, Cadoret-Manier will remain in a full-time capacity through March 15, after which she will serve as an advisor for a period of time.   “I thank Onaiza for ...